Novartis
Novartis operates in over 140 countries, providing innovative and generic medicines, as well as eye care, to more than 250 million people worldwide.
Global Presence
Novartis operates in over 140 countries, delivering its innovative and generic medicines as well as eye care products worldwide. This extensive reach enables Novartis to serve a broad population, with their medicines impacting more than 250 million people globally. The company's worldwide presence underscores its commitment to improving and extending people's lives through sustained healthcare efforts.
Innovative Medicines and Therapeutic Areas
Novartis is dedicated to the development of innovative medicines, encompassing a wide array of therapeutic areas. Key focus areas include cardiovascular, renal and metabolic conditions, immunology, neuroscience, oncology, and ophthalmology. This holistic approach to medicine allows Novartis to address diverse healthcare needs and pioneer new treatments that enhance patient care.
Research and Development
Engaged substantially in research and development, Novartis prioritizes progressing medical science across multiple domains. The company supports healthcare professionals through resources such as clinical trial information, medical congresses and events, and managed access programs. By maintaining a comprehensive pipeline of developmental drugs and therapies, Novartis continuously strives to bring innovative medical solutions to market.
Sustainability Initiatives
Novartis is committed to environmental sustainability, actively working towards water neutrality and reducing its carbon footprint. These initiatives reflect the company's dedication to minimizing environmental impact while delivering healthcare solutions. Sustainability forms a core component of Novartis' operational strategy, aligning with a broader commitment to ethical practices and corporate responsibility.
Ethical Behavior and Compliance
A strong commitment to ethical behavior and compliance defines Novartis' operations worldwide. The company enforces strict adherence to ethical standards across its global activities, ensuring responsible business conduct. Annually, Novartis publishes the 'Novartis in Society Integrated Report,' which details its business impact and ESG performance, providing transparency and accountability in its corporate endeavors.